MDXH

MDxHealth SA MDXH

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 26 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$107.88M

Quarter to Dec 31

Net income

$-33.52M

Quarter to Dec 31

Free cash flow

$-3.35M

Quarter to Dec 31

Operating margin

-13.4%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$6.79M total
Bleichroeder LP
$3.03M0.0%
MVM Partners, LLC
$1.91M0.0%
PERKINS CAPITAL MANAGEMENT INC
$579.7K-4.4%
CITADEL ADVISORS LLC
$209.3K+754.7%
JANE STREET GROUP, LLC
$206.6KNew
GSA CAPITAL PARTNERS LLP
$198.0K+4245.3%
RENAISSANCE TECHNOLOGIES LLC
$133.5K+6.7%
MILLENNIUM MANAGEMENT LLC
$93.8K-58.1%
Squarepoint Ops LLC
$82.2KNew
XTX Topco Ltd
$80.1K+417.1%
HRT FINANCIAL LP
$75.0K+1529.2%
BlackRock, Inc.
$60.4K+41.0%
Virtu Financial LLC
$55.0KNew
Ground Swell Capital, LLC
$36.2KNew
Tower Research Capital LLC (TRC)
$15.0KNew
FAS Wealth Partners, Inc.
$9.3K0.0%
Lido Advisors, LLC
$8.3K+92.9%
Intesa Sanpaolo Wealth Management
$4.1K0.0%
Cambridge Investment Research Advisors, Inc.
$4.0K0.0%
MORGAN STANLEY
$313-95.3%
WELLS FARGO & COMPANY/MN
$820.0%
Monetary Solutions, Ltd
$350.0%
SBI Securities Co., Ltd.
$120.0%
BARCLAYS PLC
$7-97.7%
Farther Finance Advisors, LLC
$40.0%
See all 26 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

MDXH key financials by period

Reported revenue, net income and operating margin by fiscal year, from MDxHealth SA's annual filings on SEC EDGAR.

MDxHealth SA reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$107.9M$-33.5M-13.4%
FY 2024$90.0M$-38.1M-27.5%
FY 2023$70.2M$-43.1M-38.9%
FY 2022$37.1M$-44.0M-102.3%
FY 2021$22.2M$-29.0M-120.7%
FY 2020$18.5M$-28.7M-146.9%
Source: MDXH filings on SEC EDGAR →

MDXH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MDxHealth SA (MDXH): stock profile, AI score and financials

MDxHealth SA (MDXH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MDXH is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 26 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), MDxHealth SA reports quarterly revenue of $107.9M, net income of $-33.5M, an operating margin of -13.4%. Top institutional holders of MDXH by reported 13-F value include Bleichroeder, MVM Partners, PERKINS CAPITAL MANAGEMENT, based on the most recent SEC filings. MDXH trades on the Nasdaq exchange and files with the SEC under CIK 1872529. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDXH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MDxHealth SA directly from SEC EDGAR.

SEC EDGAR: CIK 1872529 →